Rose-hip – a new hope for sufferers of joint pain and osteoarthritis Wednesday 1 March 2006 PDF Print Rose-hip can help alleviate joint pain in patients with knee, hip, and hand osteoarthritis, according to latest research. In the study, a randomized, double-blind, placebo-controlled clinical trial published in the Scandinavian Journal of Rheumatology (Aug 2005)1, 82% of patients reported a reduction in pain after 3 weeks of active treatment with GOPO - the active compound isolated from Rosa canina, a type of rose-hip. The research could give new hope to the 9 million people in the UK who suffer from painful joints2 due to arthritis and related conditions but who are keen to maintain an active life. In comparison, one of the largest long-term studies on glucosamine3, currently the most popular supplement for joint health, showed only a 40% response rate to treatment and that it took up to 12 weeks before the subjects reported feeling improvement. The research also found that GOPO alleviated pain to an extent that there was a significant reduction in the consumption of traditional painkillers such as paracetamol, ibuprofen, and non-steroidal anti-inflammatory drugs (NSAID’s) – a key benefit not observed in studies on glucosamine. Although typical treatments for the pain and inflammation caused by arthritis, NSAID’s can cause serious side effects if used over a prolonged period including abdominal pain, heartburn, nausea, and vomiting. “I was very interested to see the results of this research, which show rose-hip extract to have a very quick effect in reducing osteoarthritic pain in the hip, knee, and hand. This study suggests that rose-hip extract offers potential relief from pain for osteoarthritis sufferers, without the side effects that are often found with conventional anti-inflammatory drugs or pain killers”, says Dr Rod Hughes, Consultant Rheumatologist at St Peter’s Hospital in Surrey. The study, recently presented at the 10th World Congress on Arthritis in December 2005, is a continuation of extensive research into anti-inflammatory efficacy of GOPO in osteoarthritis. The Scandinavian Journal of Rheumatology is one of the leading international journals in the field of arthritis and rheumatology. Unfortunately due to the drying process that is needed to isolate the active anti-inflammatory compound from the sub-species of rose-hip, GOPO is not available in a normal diet and can only be taken in the form of a food supplement. LitoZin Joint Health, from Lanes, is the only supplement containing GOPO and is specifically formulated for maintaining joint health. Notes for editors: For more information or to speak to an expert please contact: Simon Hackett Spink Consumer Relations Tel: 01444 484888 Email: firstname.lastname@example.org / email@example.com LitoZin Joint Health is available in Boots, independent pharmacies and health food stores, and is priced at £19.99 for 120 capsules. For more information on LitoZin Joint Health, please see www.litozin.co.uk For more information on arthritis, please see Arthritis Care (www.arthritiscare.org.uk ) and Arthritis Research Campaign (www.arc.org.uk) About Lanes G R Lane Health Products Ltd (Lanes) is one of the major natural medicine companies in the UK and manufactures well-known products such as Olbas, Kalms, Quiet Life and Aquaban. Established in the 1930’s by Gilbert Lane - an early supporter of the idea that we can improve our health through diet and the use of carefully selected plants and nutrients – Lanes remains a family owned business and is chaired by Gilbert’s grand-daughter, Janet Lane. References 1 A powder made from seeds and shells of a rose-hip subspecies (Rosa canina l.) reduces symptoms of knee and hip osteoarthritis: A randomized, double-blind, placebo-controlled clinical trial, Scand J Rheumatol 34:302-308, July – August 2005 by Winther, K. Apel, K and Thomsborg,G., 2 Statistics from the Arthritis Research Campaign 3 Long term effects of glucosamine sulfate on osteoarthritis progression: a randomised, placebo-controlled clinical trial JY. Reginster , R. Deroisy , LC. Deroisy, et al., Lancet , 2001, vol. 357, pp. 251—256) This press release was distributed by ResponseSource Press Release Wire on behalf of Spink in the following categories: Men's Interest, Health, Leisure & Hobbies, Home & Garden, Women's Interest & Beauty, for more information visit http://pressreleasewire.responsesource.com/about.